S. Maki

1.0k total citations
47 papers, 826 citations indexed

About

S. Maki is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. Maki has authored 47 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in S. Maki's work include Renal Diseases and Glomerulopathies (11 papers), Magnetism in coordination complexes (8 papers) and Organic and Molecular Conductors Research (8 papers). S. Maki is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Magnetism in coordination complexes (8 papers) and Organic and Molecular Conductors Research (8 papers). S. Maki collaborates with scholars based in Japan, United States and China. S. Maki's co-authors include Kazuo Yoshioka, Tamiko Takemura, Katsumi Murakami, Morihito Okada, Shinjiro Hino, Hiroyuki Miyamoto, Norihisa Akano, Yasuo Takekoshi, Jörgen Wieslander and Megumi Kagawa and has published in prestigious journals such as Physical review. B, Condensed matter, Blood and The Journal of Immunology.

In The Last Decade

S. Maki

44 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Maki Japan 13 297 253 186 151 137 47 826
Satoshi Hino Japan 21 128 0.4× 627 2.5× 123 0.7× 298 2.0× 50 0.4× 59 1.3k
Daniel A. Savino United States 13 173 0.6× 136 0.5× 106 0.6× 230 1.5× 48 0.4× 19 1.7k
J-M Freyssinet France 10 23 0.1× 320 1.3× 111 0.6× 38 0.3× 34 0.2× 10 827
Aurora Poon Australia 16 156 0.5× 126 0.5× 269 1.4× 163 1.1× 4 0.0× 32 800
Carolyn C. Lamb United States 13 19 0.1× 217 0.9× 185 1.0× 297 2.0× 60 0.4× 16 789
Cecilia Wassberg Sweden 14 86 0.3× 241 1.0× 332 1.8× 312 2.1× 6 0.0× 33 982
Dan Combs United States 8 17 0.1× 335 1.3× 143 0.8× 233 1.5× 12 0.1× 10 1.2k
Craig J. Reist United States 17 16 0.1× 361 1.4× 260 1.4× 492 3.3× 16 0.1× 27 1.4k
Koen Mertens Netherlands 34 49 0.2× 558 2.2× 301 1.6× 84 0.6× 88 0.6× 80 3.8k
Sidney Bennett United States 17 33 0.1× 424 1.7× 196 1.1× 424 2.8× 19 0.1× 24 1.4k

Countries citing papers authored by S. Maki

Since Specialization
Citations

This map shows the geographic impact of S. Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Maki more than expected).

Fields of papers citing papers by S. Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Maki. The network helps show where S. Maki may publish in the future.

Co-authorship network of co-authors of S. Maki

This figure shows the co-authorship network connecting the top 25 collaborators of S. Maki. A scholar is included among the top collaborators of S. Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Maki. S. Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Igawa, Satoshi, Keigo Gohda, Tomoya Fukui, et al.. (2014). Circulating tumor cells as a prognostic factor in patients with small cell lung cancer. Oncology Letters. 7(5). 1469–1473. 56 indexed citations
2.
Igawa, Satoshi, S. Maki, Sakiko Otani, et al.. (2014). Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report. Case Reports in Oncology. 7(2). 401–406. 3 indexed citations
3.
Igawa, Satoshi, Jiichiro Sasaki, Sakiko Otani, et al.. (2013). Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer. Chemotherapy. 59(2). 99–105. 5 indexed citations
4.
Igawa, Satoshi, Nobuyuki Yanagisawa, Michiko Kimura, et al.. (2013). Successful Chemotherapy with Carboplatin and S-1 for Thymic Carcinoma: A Case Report. Case Reports in Oncology. 6(3). 526–530. 1 indexed citations
5.
Yamamoto, Michiko, Shinichiro Ryuge, Ken Katono, et al.. (2012). Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 69(6). 1529–1536. 4 indexed citations
6.
Igawa, Satoshi, Shinichiro Ryuge, Sakiko Otani, et al.. (2012). Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression. Chemotherapy. 58(4). 313–320. 21 indexed citations
7.
Yamamoto, Michiko, Shinichiro Ryuge, Yoshinao Nagashima, et al.. (2011). Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 69(4). 1005–1011. 13 indexed citations
8.
Matsumura, Hiroyoshi, Yoshikuni Nakamura, S. Maki, et al.. (2008). Crystal structure of RNA aptamer in complex with human immunoglobulin G. Acta Crystallographica Section A Foundations of Crystallography. 64(a1). C309–C309. 3 indexed citations
9.
Maki, S., Ryosuke Murai, Hiroshi Yoshikawa, et al.. (2008). Protein crystallization in a 100 nl solution with new stirring equipment. Journal of Synchrotron Radiation. 15(3). 269–272. 4 indexed citations
10.
Morita, Yasushi, T. Murata, Eiji Miyazaki, et al.. (2004). Hydrogen-bonded charge-transfer complexes of TTFs containing nucleobase or imidazole moiety. Journal de Physique IV (Proceedings). 114. 471–474. 1 indexed citations
11.
Uji, Shinya, C. Terakura, Taichi Terashima, et al.. (2001). Correlation between rapid oscillation and phase diagram in quasi-one-dimensional organic conductor (TMTSF)2ClO4. Current Applied Physics. 1(1). 77–83. 1 indexed citations
12.
Maki, S., Toshio Tagawa, & Hiroyuki Ozoe. (2001). NATURAL CONVECTION OF AIR IN A SHALLOW CYLINDER OF THE ASPECT RATIO THREE UNDER A HIGH MAGNETIC FIELD. 1 indexed citations
13.
Uji, Shinya, C. Terakura, H. Aoki, et al.. (1998). Quantum Hall Effect and Interlayer Resistance for the Organic Conductor(TMTSF)2AsF6.. The Review of High Pressure Science and Technology. 7. 493–495. 4 indexed citations
14.
Yoshioka, Kazuo & S. Maki. (1995). Human IgA nephritis: immunocytochemical evidence of a chronic inflammatory proliferative disorder.. PubMed. 10(1). 203–12. 6 indexed citations
15.
Murakami, Katsumi, Kazuo Yoshioka, Norihisa Akano, et al.. (1994). Combined therapy in children and adolescents with IgA nephropathy.. PubMed. 36(1). 38–43. 12 indexed citations
16.
Takemura, Tamiko, Kazuo Yoshioka, Katsumi Murakami, et al.. (1994). Cellular localization of inflammatory cytokines in human glomerulonephritis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 424(5). 459–64. 114 indexed citations
17.
Hiramatsu, Y, Akira Sakai, S. Maki, Tetsuya Nomura, & Masayuki Osawa. (1992). [A case of abdominal aortic pseudoaneurysm due to Salmonella enteritidis septicemia].. PubMed. 93(2). 212–5. 1 indexed citations
18.
Yoshioka, Kazuo, Keizo Murakami, & S. Maki. (1992). [Growth factors: a regulator of renal function].. PubMed. 50(12). 2931–6.
19.
Fukui, Hiromu, Hidekazu Kamitsuji, T Nagao, et al.. (1989). Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Thrombosis Research. 56(6). 667–675. 37 indexed citations
20.
Yoshioka, Kazuo, Hiroshi Miyata, & S. Maki. (1981). Fibrinogen and fibrin derivatives in serum from normal and sick children. Thrombosis Research. 22(1-2). 25–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026